These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31773445)

  • 1. Improving Monitoring of Engagement in HIV Care for Women in Option B+: A Pilot Test of Biometric Fingerprint Scanning in Lilongwe, Malawi.
    Bengtson AM; Kumwenda W; Lurie M; Klyn B; Owino M; Miller WC; Go V; Hosseinipour MC
    AIDS Behav; 2020 Feb; 24(2):551-559. PubMed ID: 31773445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond mobile phones: exploring using technology to support sustained engagement in care for HIV-infected women on antiretroviral therapy.
    Bengtson AM; Kumwenda W; Lurie M; Kutengule A; Go V; Miller WC; Cui E; Owino M; Hosseinipour M
    AIDS Care; 2020 Aug; 32(8):959-964. PubMed ID: 32138524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.
    Hauser BM; Miller WC; Tweya H; Speight C; Mtande T; Phiri S; Ball LM; Hosseinipour MC; Hoffman IF; Rosenberg NE
    Int J STD AIDS; 2018 Feb; 29(2):185-194. PubMed ID: 28750577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
    DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
    BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
    McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "A way of escaping": a qualitative study exploring reasons for clinic transferring and its impact on engagement in care among women in Option B.
    Bengtson AM; Go V; Kumwenda W; Lurie M; Kutengule A; Owino M; Hosseinipour M
    AIDS Care; 2020 Jan; 32(1):72-75. PubMed ID: 31067986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing stakeholder perceptions of the acceptability and feasibility of national scale-up for a dual HIV/syphilis rapid diagnostic test in Malawi.
    Maddox BLP; Wright SS; Namadingo H; Bowen VB; Chipungu GA; Kamb ML
    Sex Transm Infect; 2017 Dec; 93(S4):S59-S64. PubMed ID: 29223964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
    Cataldo F; Chiwaula L; Nkhata M; van Lettow M; Kasende F; Rosenberg NE; Tweya H; Sampathkumar V; Hosseinipour M; Schouten E; Kapito-Tembo A; Eliya M; Chimbwandira F; Phiri S;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):517-522. PubMed ID: 28045712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    Mwapasa V; Joseph J; Tchereni T; Jousset A; Gunda A
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S123-S131. PubMed ID: 28498181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges.
    Gunda A; Jousset A; Tchereni T; Joseph J; Mwapasa V
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S132-S139. PubMed ID: 28498182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
    Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
    BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    Joseph J; Gotora T; Erlwanger AS; Mushavi A; Zizhou S; Masuka N; Boeke CE; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S190-S197. PubMed ID: 28498189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi.
    Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Harrington BJ; DiPrete B; Wallie S; Jumbe A; Limarzi L; Hosseinipour MC
    PLoS One; 2018; 13(12):e0209052. PubMed ID: 30543685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
    Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
    Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.
    Dzangare J; Takarinda KC; Harries AD; Tayler-Smith K; Mhangara M; Apollo TM; Mushavi A; Chimwaza A; Sithole N; Magure T; Mpofu A; Dube F; Mugurungi O
    Trop Med Int Health; 2016 Feb; 21(2):202-9. PubMed ID: 26555353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness and perceived fairness of Option B+ in Malawi: A population-level perspective.
    Yeatman S; Trinitapoli J
    J Int AIDS Soc; 2017 Mar; 20(1):21467. PubMed ID: 28362070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model.
    Gamell A; Luwanda LB; Kalinjuma AV; Samson L; Ntamatungiro AJ; Weisser M; Gingo W; Tanner M; Hatz C; Letang E; Battegay M;
    PLoS One; 2017; 12(7):e0181096. PubMed ID: 28704472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.